EUCTR2015-000730-30-GB
Active, not recruiting
Not Applicable
A randomised clinical trial comparing endovenous laser ablation and mechanochemical ablation (ClariVein®) in the management of superficial venous insufficiency. - Laser Ablation versus Mechanochemical Ablation (LAMA) trial
Hull and East Yorkshire Hospitals NHS Trust0 sitesApril 14, 2015
ConditionsVaricose veins (VVs) or Superficial Venous Insufficiency (SVI) of the legs results from inflammation mediated damage to vein structure, allowing reverse flow. SVI affects 30% of adults and is associated with symptoms causing pain and disabilityfurthermore 3-10% have soft tissue damage and 1-2% suffer with venous ulcer disease.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Varicose veins (VVs) or Superficial Venous Insufficiency (SVI) of the legs results from inflammation mediated damage to vein structure, allowing reverse flow. SVI affects 30% of adults and is associated with symptoms causing pain and disability
- Sponsor
- Hull and East Yorkshire Hospitals NHS Trust
- Status
- Active, not recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Age 18 or over
- •\- Symptomatic SVI which will likely benefit from treatment in the opinion of an experienced specialist and the participant
- •\- Clinical grades C2\-C6 on the CEAP system
- •\- Superficial axial incompetence with proposed treatment lengths of at least 10cm
- •\- Treatment with either endovenous laser ablation or mechanochemical ablation is technically feasible in the view of an experienced endovenous specialist
- •\- Patient is willing to participate (including acceptance of randomisation to either treatment) and give valid, informed consent in the English language
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 140
Exclusion Criteria
- •\- One of the treatments is thought to be preferable by either the patient or an experienced endovenous specialist
- •\- Unwilling or inability to comply with the requirements for follow\-up visits
- •\- Known allergy to any medications used during treatment
- •\- Known right to left circulatory shunt
- •\- Evidence of acute deep venous thrombosis or complete ipsilateral occlusion
- •\- Pelvic vein insufficiency
- •\- Active or recent thrombophlebitis (within 6 weeks)
- •\- Impalpable foot pulses with Ankle\-Brachial Pressure Index of less than 0\.8
- •\- Pregnancy or breast feeding
- •\- Active malignancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Randomised clinical trial comparing endovenous laser ablation with cryostripping for varicose veins: two-year resultsISRCTN33832691The Mesos Medical Centre (Mesos Medisch Centrum Utrecht) (Netherlands)120
Completed
Not Applicable
Randomised clinical trial comparing endovenous laser ablation of the great saphenous vein with and without ligation of the saphenofemoral junction, with a two-year follow-upISRCTN60300873The Mesos Medical Centre (Mesos Medisch Centrum) (The Netherlands)43
Completed
Not Applicable
Randomized controlled study comparing endovenous laser ablation with stripping, in patients with varicose veins due to greater saphenous vein insufficiencyVaricose veinsCirculatory SystemISRCTN16747172Public Danish Health Insurance, Amtsrådsforeningen (Denmark)240
Completed
Phase 3
Ketamine vs. morphine for limb injurypper and Lower limb trauma.Injuries to shoulder and upper arm to injuries to ankle and footS40 to S99IRCT2016050515941N3Amirhossein mirafzal60
Not yet recruiting
Not Applicable
A scientific research to be conducted among women in labour to reduce labour pain using either of the two injectionsCTRI/2022/08/045029Indira Gandhi Medical college and Research Institute